Gebauer Julie Jarecke

A 13% one-year stock decline, visible only through routine grant prices, is the signal in Julie Jarecke Gebauer's Form 4 record, which splits across two related entities: Willis Towers Watson (340 transactions since 2016, 175,901 shares sold, zero bought) and its predecessor Towers Watson & Co. (82 transactions, 2010-2016, 262,150 shares sold), the changeover marking the January 2016 merger that created the modern company. Her current activity is entirely grant-funded — small recurring share awards and tax-withholding transactions, with no open-market sales. The prices attached to those withholdings show a gradual decline: $337.95 in April 2025, down to $307.32 by July, back up to $337.39 in October, down to $317.52 in November, and further to $290.70-$297.64 by April 2026 — roughly a 13% net decline over the year, with meaningful volatility along the way.